Literature DB >> 9414268

c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway.

H Ueno1, K Sasaki, H Honda, T Nakamoto, T Yamagata, K Miyagawa, K Mitani, Y Yazaki, H Hirai.   

Abstract

Interleukin-4 (IL-4) is a cytokine that induces both proliferation and differentiation and suppresses apoptosis of B cells. Although IL-4 has been shown to activate the phosphatidylinositol 3' (PI3)-kinase pathway, the role of PI3 kinase in the IL-4 receptor (IL-4R) signaling remains unclear. In this study, we demonstrated that c-Cbl proto-oncogene product is inducibly phosphorylated on tyrosine residues and is associated with the p85 subunit of PI3-kinase by IL-4 stimulation. Overexpression of c-Cbl enhances the PI3-kinase activity and, at the same time, mitogenic activity and survival of cells in the presence of IL-4. However, these effects of c-Cbl were abolished by wortmannin, a specific inhibitor for the PI3 kinase pathway, or by a point mutation at tyrosine 731 of c-Cbl, which is a major binding site for p85. These results indicate that c-Cbl plays a role in linking IL-4R with the PI3 kinase pathway and thus enhancing the mitogenic and survival signals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9414268

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Platelet alpha IIb-beta 3 integrin engagement induces the tyrosine phosphorylation of Cbl and its association with phosphoinositide 3-kinase and Syk.

Authors:  A Saci; F Rendu; C Bachelot-Loza
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

Review 2.  Roles of E3 ubiquitin ligases in cell adhesion and migration.

Authors:  Cai Huang
Journal:  Cell Adh Migr       Date:  2010-01-18       Impact factor: 3.405

3.  Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells.

Authors:  S Kagami; H Saeki; M Komine; T Kakinuma; Y Tsunemi; K Nakamura; K Sasaki; A Asahina; K Tamaki
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 4.  c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.

Authors:  Christine B F Thien; Wallace Y Langdon
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

5.  Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation.

Authors:  Vanessa Scanlon; Bhavita Walia; Jungeun Yu; Marc Hansen; Hicham Drissi; Peter Maye; Archana Sanjay
Journal:  Bone       Date:  2016-11-22       Impact factor: 4.398

6.  Tyrosine phosphorylated c-Cbl regulates platelet functional responses mediated by outside-in signaling.

Authors:  Lorena Buitrago; Wallace Y Langdon; Archana Sanjay; Satya P Kunapuli
Journal:  Blood       Date:  2011-10-03       Impact factor: 22.113

Review 7.  Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.

Authors:  Seishi Ogawa; Masashi Sanada; Lee-Young Shih; Takahiro Suzuki; Makoto Otsu; Hiromitsu Nakauchi; H Philip Koeffler
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

8.  Identification of components of the host type IA phosphoinositide 3-kinase pathway that promote internalization of Listeria monocytogenes.

Authors:  Shahanawaz Jiwani; Yi Wang; Georgina C Dowd; Antonella Gianfelice; Phannipha Pichestapong; Balramakrishna Gavicherla; Neyda Vanbennekom; Keith Ireton
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

9.  Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.

Authors:  Naga Suresh Adapala; Danielle Holland; Vanessa Scanlon; Mary F Barbe; Wallace Y Langdon; Alexander Y Tsygankov; Joseph A Lorenzo; Archana Sanjay
Journal:  Bone       Date:  2014-07-01       Impact factor: 4.398

10.  c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.

Authors:  Jae J Song; Joo-Hang Kim; Bo K Sun; Marco A Alcala; David L Bartlett; Yong J Lee
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.